X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (200) 200
life sciences & biomedicine (159) 159
humans (141) 141
chemistry (79) 79
heterocyclic compounds (73) 73
organic chemistry (72) 72
metallurgy (70) 70
human necessities (58) 58
hygiene (58) 58
medical or veterinary science (58) 58
preparations for medical, dental, or toilet purposes (57) 57
animals (56) 56
female (56) 56
specific therapeutic activity of chemical compounds ormedicinal preparations (56) 56
male (50) 50
oncology (45) 45
cell biology (36) 36
physical sciences (28) 28
middle aged (27) 27
biochemistry & molecular biology (26) 26
adult (24) 24
mice (23) 23
proteins (21) 21
aged (19) 19
cancer (19) 19
physics (19) 19
hematology (17) 17
pharmacology & pharmacy (17) 17
research (17) 17
technology (17) 17
cells, cultured (16) 16
cell cycle (15) 15
optics (15) 15
apoptosis (14) 14
biology (14) 14
mutation (14) 14
rats (14) 14
binding (13) 13
health aspects (13) 13
analysis (12) 12
antineoplastic agents - therapeutic use (12) 12
apoptosis - drug effects (12) 12
calcium (12) 12
cardiovascular system & cardiology (12) 12
cell line, tumor (12) 12
signal transduction (12) 12
bioscience (11) 11
cell (11) 11
cycle (11) 11
landes (11) 11
organogenesis (11) 11
akt (10) 10
cell proliferation (10) 10
engineering (10) 10
genetics & heredity (10) 10
multidisciplinary sciences (10) 10
phosphorylation (10) 10
proliferating cell nuclear antigen - metabolism (10) 10
science & technology - other topics (10) 10
610 medicine & health (9) 9
aged, 80 and over (9) 9
cardiac & cardiovascular systems (9) 9
cell line (9) 9
dna damage (9) 9
dna repair (9) 9
physics, applied (9) 9
protein binding (9) 9
raf (9) 9
signal transduction - drug effects (9) 9
time factors (9) 9
binding sites (8) 8
child (8) 8
clinic for cardiology (8) 8
disease progression (8) 8
drug resistance (8) 8
genetic aspects (8) 8
immunohistochemistry (8) 8
immunology (8) 8
microbiology (8) 8
pi3k (8) 8
research article (8) 8
risk factors (8) 8
stilbenes - pharmacology (8) 8
targeted therapy (8) 8
usage (8) 8
adolescent (7) 7
biotechnology & applied microbiology (7) 7
breast cancer (7) 7
cell cycle - drug effects (7) 7
disease models, animal (7) 7
endothelium (7) 7
engineering, electrical & electronic (7) 7
infectious diseases (7) 7
leukemia (7) 7
medicine (7) 7
medicine, research & experimental (7) 7
mice, inbred c57bl (7) 7
neoplasms - drug therapy (7) 7
pcna (7) 7
phenotype (7) 7
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (401) 401
Italian (41) 41
French (21) 21
Spanish (18) 18
Chinese (10) 10
German (7) 7
Korean (6) 6
Portuguese (3) 3
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Leukemia, ISSN 1476-5551, 03/2008, Volume 22, Issue 4, pp. 708 - 722
The Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways are frequently activated in leukemia and other hematopoietic disorders by upstream mutations in... 
Oncology | Life Sciences & Biomedicine | Hematology | Science & Technology | Leukemia - drug therapy | Leukemia - pathology | Signal Transduction - drug effects | Apoptosis - drug effects | Humans | Drug Delivery Systems | Control | Translocation (Genetics) | Cytokines | Leukemia | Genetic aspects | Cellular signal transduction | Research | Health aspects | Index Medicus
Journal Article
Leukemia, ISSN 1476-5551, 04/2011, Volume 25, Issue 7, pp. 1080 - 1094
The Ras/Raf/mitogen-activated protein kinase (MEK)/extracellular signal-regulated kinase (ERK) pathway is often implicated in sensitivity and resistance to... 
targeted therapy | Ras | therapeutic sensitivity | Raf | resistance | ERK | Oncology | Life Sciences & Biomedicine | Hematology | Science & Technology | ras Proteins - genetics | MAP Kinase Signaling System - physiology | Mitogen-Activated Protein Kinase Kinases - genetics | Apoptosis - drug effects | raf Kinases - antagonists & inhibitors | Humans | Neoplasm Proteins - physiology | Mitogen-Activated Protein Kinase Kinases - physiology | Extracellular Signal-Regulated MAP Kinases - antagonists & inhibitors | Neoplasm Proteins - antagonists & inhibitors | Antineoplastic Agents - therapeutic use | Molecular Targeted Therapy | Phosphatidylinositol 3-Kinases - antagonists & inhibitors | Extracellular Signal-Regulated MAP Kinases - genetics | Gene Expression Regulation, Leukemic - genetics | raf Kinases - physiology | MAP Kinase Signaling System - genetics | Drug Design | Antineoplastic Agents - pharmacology | Extracellular Signal-Regulated MAP Kinases - physiology | Neoplasm Proteins - genetics | raf Kinases - genetics | ras Proteins - physiology | Cell Division - genetics | Mitogen-Activated Protein Kinase Kinases - antagonists & inhibitors | ras Proteins - antagonists & inhibitors | Gene Expression Regulation, Leukemic - drug effects | Leukemia - drug therapy | Cell Division - drug effects | Phosphatidylinositol 3-Kinases - genetics | Drug Resistance, Neoplasm - genetics | MAP Kinase Signaling System - drug effects | Models, Biological | Phosphatidylinositol 3-Kinases - physiology | Apoptosis - physiology | Drug Resistance, Neoplasm - physiology | Drug Resistance, Neoplasm - drug effects | Chemotherapy | Extracellular signal-regulated kinases | Leukemia | Physiological aspects | Genetic aspects | Research | Drug therapy | Health aspects | Mitogen-activated protein kinases | Cancer | Index Medicus
Journal Article